DXC Technology Faces Class Action for Securities Fraudby Lilu Anderson 20.09.2024Investors of DXC Technology are urged to join class action for alleged securities fraud between May 2021 and May 2024.
Sony’s Minato Testnet Boosts Blockchain Adoptionby John Darbie 28.08.2024Sony launches Ethereum Layer-2 testnet Minato, enhancing blockchain adoption through developer support and partnerships.
Genmab Reports 36% Revenue Growth in H1 2024by Mark Eisenberg 15.08.2024Genmab's H1 2024 results show 36% revenue growth; DARZALEX sales surge, and strategic acquisition of ProfoundBio boosts future potential.
Mercury Systems Shares Surge on Q4 Earnings Beatby Mark Eisenberg 14.08.2024Mercury Systems shares rose 10% after Q4 earnings beat expectations with $248.6M in revenue and a $0.23 EPS.
Trinity Biotech Granted Extension to Meet Nasdaq Complianceby Lilu Anderson 07.08.2024Trinity Biotech has until October 31, 2024, to meet the Nasdaq MVPHS requirement, securing a chance to maintain its listing.
ByteDance Partners with Broadcom for AI Chip Supply amidst U.S. Banby Mark Eisenberg 24.06.2024ByteDance partners with Broadcom to develop a cutting-edge 5nm AI chip, aiming to secure a reliable supply amidst U.S. export ...
Sharps Technology vs. Competitors: A Profitability Reviewby Lilu Anderson 23.06.2024"Sharps Technology (STSS) vs. Competitors: A review of profitability, ownership, volatility, ratings, and valuation in the medical device sector."
Czech National Bank Increases Stake in Tyler Technologiesby Lilu Anderson 22.06.2024Czech National Bank boosts stake in Tyler Technologies (NYSE:TYL) by 0.6% to $3.15M in Q1. Major investors and analysts show ...
Align Technology Sees Diverse Investor Interest and Mixed Ratingsby Lilu Anderson 22.06.2024AIG sells 4,921 shares of Align Technology, reducing holdings by 19%. Major investors and analysts shift positions and ratings. Stock ...
Recon Technology (NASDAQ:RCON) Dips Below 200-Day Averageby Lilu Anderson 22.06.2024Recon Technology (NASDAQ:RCON) stock dips below 200-day average, hits $1.38; analysts issue "sell" rating, highlighting cautious future outlook.